High definition Lasofoxifene - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity – Ruifu

Short Description:

Name: 2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone 

CAS: 32384-65-9

Appearance: Pale Yellow Oily Liquid

Purity: ≥97.0% (GC) 

Intermediate of Dapagliflozin(CAS: 461432-26-8) and Canagliflozin (CAS: 842133-18-0)

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

, , ,
High definition Lasofoxifene - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity – Ruifu Detail:

Manufacturer Supply with High Purity and Stable Quality
Chemical Name: Lasofoxifene Tartrate 
CAS: 190791-29-8
Appearance: White to Off-White Powder
Chiral Purity: ≥99.0%   Purity: ≥98.0% (HPLC)
Lasofoxifene Tartrate (CAS: 190791-29-8) in the treatment of Postmenopausal Osteoporosis

Chemical Name Lasofoxifene Tartrate
Synonyms (5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol Tartrate Oporia
CAS Number 190791-29-8
CAT Number RF-API20
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C28H31NO2.ClH
Molecular Weight 450.019
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-White Powder 
Moisture (K.F) ≤0.50%
Heavy Metals ≤20ppm
Chiral Purity ≥99.0%
Purity / Analysis Method ≥98.0% (HPLC)
Loss on Drying ≤0.50%
Residue on Ignition ≤0.50%
Test Standard Chinese Pharmacopoeia (CP); Enterprise Standard
Usage Active Pharmaceutical Ingredient (API); Postmenopausal Osteoporosis

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1
2

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Lasofoxifene Tartrate (CAS: 190791-29-8) with high quality.
Lasofoxifene Tartrate is a third-generation, non-steroidal selective estrogen receptor modulator (SERM). It selectively binds to human ERalpha with an IC50 value of 1.5 nM and inhibits bone loss in ovariectomized rats. In clinical studies of postmenopausal osteoporosis, 0.5 mg/day lasofoxifene was associated with reduced risks of nonvertebral and vertebral fractures, ER-positive breast cancer, coronary heart disease, and stroke but an increased risk of venous thromboembolic events. Lasofoxifene has also been shown to act as an inverse agonist at the CB2 cannabinoid receptor, indicating its potential to be repurposed as a therapeutic for indications wherein CB2 is a target. 


Product detail pictures:

High definition Lasofoxifene - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity  – Ruifu detail pictures


Related Product Guide:

High definition Lasofoxifene - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity – Ruifu , The product will supply to all over the world, such as: , , ,

  • 5 Stars By from -

    5 Stars By from -
    Write your message here and send it to us